SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001628280-23-000354
Filing Date
2023-01-04
Accepted
2023-01-04 20:08:09
Documents
1
Period of Report
2022-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_167288087288104.html 4/A  
1 FORM 4/A wf-form4a_167288087288104.xml 4/A 3441
  Complete submission text file 0001628280-23-000354.txt   4885
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address
Stonehouse Jon P (Reporting) CIK: 0001385496 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36783 | Film No.: 23509317